Skip to content
Riskpilot
← Back to search
Sign in
Get full access
EnliTISA Pharmaceutical Sweden AB
AB
Active
Org 5592538226
Economic activity was not specified by tax authority
· NACE 0000
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
Economic activity was not specified by tax authority
/
EnliTISA Pharmaceutical Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (1)
LM
Linda Margareta Sandler
Chief Auditor
Chief Auditor
2020 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
GM
Gu Ming
Chairman
2024
LO
Lars Ole Öhman
Board of Directors
2024
JJ
Jan-Christer Janson
Board of Directors
2020
Former (2)
BI
Bengt Ingemar Samuelsson
Chairman
2022 – 2024
AJ
Anders Jesper Zacharias Haeggström
Board of Directors
2020 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on EnliTISA Pharmaceutical Sweden AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot